Approval · Notice of Compliance 19067 · 2017
MINT-CLONIDINE: Notice of Compliance 19067
Issued March 15, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19067
- Date
- March 15, 2017
- Company
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- NOVO-CLONIDINE (Teva Canada Limited)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MINT-CLONIDINE | 02462192 | Marketed |
| MINT-CLONIDINE | 02462206 | Marketed |
Medicinal ingredients
- CLONIDINE HYDROCHLORIDE 0.1 MG per TAB
- CLONIDINE HYDROCHLORIDE 0.2 MG per TAB